1. Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan

   • Aida A. Guemei
   • Jeff Cottrell
   • Chris H. Takimoto

   Original Article 30 January 2001 Pages: 283 - 290

2. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1

   • Merrill J. Egorin
   • Eleanor G. Zuhowski
   • Julie L. Eiseman

   Original Article 11 January 2001 Pages: 291 - 302

3. Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters

   • Kunihiro Kawanishi
   • Yasunari Miyagi
   • Takafumi Kudo

   Original Article 09 December 2000 Pages: 303 - 308

4. Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

   • Lia van Zuylen
   • Mats O. Karlsson
   • Alex Sparreboom

   Original Article 16 February 2001 Pages: 309 - 318

5. In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac

   • Shufeng Zhou
   • James W. Paxton
   • Lai-Ming Ching

   Original Article 01 February 2001 Pages: 319 - 326

6. Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy

   • Robert J. Morgan Jr
   • Timothy Synold
   • Jeff Longmate

   Original Article 08 December 2000 Pages: 327 - 332

7. A phase I trial of amsalog (CI-921) administered by intravenous infusion using a 5-day schedule

   • D. Fyfe
   • C. Price
   • J. Carmichael

   Original Article 28 February 2001 Pages: 333 - 337

8. The enhancement of riboflavin-mediated photo-oxidation of doxorubicin by histidine and urocanic acid

   • Avner Ramu
   • Michelle M. Mehta
   • Aleksandar Aleksic

   Original Article 27 January 2001 Pages: 338 - 346

9. A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A

   • Mirte M. Malingré
   • Jos H. Beijnen
   • Jan H.M. Schellens

   Original Article 16 February 2001 Pages: 347 - 354

10. PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential

    • Paola Della Torre
    • Arturo Podestà
    • Marco Brughera

    Original Article 17 February 2001 Pages: 355 - 360

11. Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components

    • Lucio Tentori
    • Ilaria Portarena
    • Grazia Graziani

    Original Article 07 February 2001 Pages: 361 - 369

12. Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study

    • J. Shamash
    • B. McLaren
    • R.T.D. Oliver

    Original Article 21 February 2001 Pages: 370 - 372